Prothrombin gene expression in rat kidneys provides an opportunity to examine its role in urinary stone pathogenesis

Journal of the American Society of Nephrology

Volumn 10, Issue SUPPL. 14, 1999, Pages

  Grover, Phulwinder K ^a,b   Stapleton, Alan M F ^a   Ryall, Rosemary L ^a  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; PROTHROMBIN; THROMBIN;

ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HOUSEKEEPING GENE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; RNA ANALYSIS; SEQUENCE HOMOLOGY; UROLITHIASIS;

EID: 0032706870     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Howard JE, Thomas WC: Some observations on rachitic rat cartilage of probable significance in the etiology of renal calculi. Trans Am Clin Climatol Assoc 70: 94-102, 1958
2. Ryall RL: Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J Urol 15: 155-164, 1997
3. Ryall RL, Stapleton AMF: Urinary macromolecules in calcium oxalate stone and crystal matrix: Good, bad or indifferent? In: Calcium Oxalate in Biological Systems, edited by Khan SR, Boca Raton, FL, CRC Press, 1995, pp 265-290
4. Ryall RL: Glycosaminoglycans, proteins, and stone formation: Adult themes and child's play. Pediatr Nephrol 10: 656-666, 1996
5. Morse RM, Resnick MI: A new approach to the study of urinary macromolecules as participants in calcium oxalate crystallization. J Urol 139: 869-873, 1988
6. Doyle IR, Ryall RL, Marshall VR: Inclusion of proteins into calcium oxalate crystals precipitated from human urine: A highly selective phenomenon. Clin Chem 37: 1589-1594, 1991
7. Stapleton AMF, Ryall RL: Blood coagulation proteins and urolithiasis are linked: Crystal matrix protein is the F1 activation peptide of human prothrombin. Br J Urol 75: 712-719, 1995
8. Atmani F, Opalko FJ, Khan SR: Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human urine and rat urine. Urol Res 24: 45-50, 1996
9. Stapleton AMF: Crystal matrix protein and urolithiasis: Getting blood out of a stone. Ph.D. thesis, The Flinders University of South Australia, Adelaide, 1994
10. Stapleton AMF, Dawson CJ, Grover PK, Hohmann A, Comacchio R, Boswarva V, Tang Y, Ryall RL: Further evidence linking urolithiasis and blood coagulation: Urinary prothrombin fragment 1 is present in stone matrix. Kidney Int 49: 880-888, 1996
11. Stapleton AMF, Seymour AE, Brennan JS, Doyle IR, Marshall VR, Ryall RL: Immunohistochemical distribution and quantification of crystal matrix protein. Kidney Int 44: 817-824, 1993
12. Stapleton AMF, Timme TL, Ryall RL: Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease. Br J Urol 81: 666-672, 1998
13. Grover PK, Moritz RL, Simpson RJ, Ryall RL: Inhibition of growth and aggregation of calcium oxalate crystals in vitro: A comparison of four human proteins. Eur J Biochem 253: 637-644, 1998
14. Ryall RL, Grover PK, Stapleton AMF, Barrell DK, Tang Y, Moritz RL, Simpson RJ: The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin Sci 89: 533-541, 1995
15. Khan SR: Animal models of kidney stone formation: An analysis. World J Urol 15: 236-243, 1997
16. Willfinger WW, Mackey K, Chomczynski P: The effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity. Biotechniques 22: 474-481, 1997
17. Dihanich M, Monard D: cDNA sequence of rat prothrombin [Abstract]. Nucleic Acids Res 18: 4251, 1990
18. Jamison CS, Degen SJF: Prenatal and postnatal expression of mRNA coding for rat prothrombin. Biochim Biophys Acta 1088: 208-216, 1991
19. Sekiya F, Usui H, Inoue K, Fukudome K, Morita T: Activation of prothrombin by a novel membrane-associated protease. J Biol Chem 269: 32441-32445, 1994
20. Suzuki K, Suga K, Miyazawa K, Tsugawa R: Where is the origin of crystal matrix protein? Expression of prothrombin mRNA in human and rat kidney [Abstract]. Br J Urol 80[Suppl 2]: 322, 1997
21. Gurwitz D, Cunningham DD: Thrombin modulates and reverses neuroblastoma neurite outgrowth. P roc Natl Acad Sci USA 85: 3440-3444, 1988
22. Jalink K, Moolenaar WH: Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messages. J Cell Biol 118: 411-419, 1992
23. Dihanich M, Kaser M, Reinhard F, Cunningham D, Monard D: Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6: 575-581, 1991
24. Wagner SL, Geddes JW, Cotman CW, Lau AL, Gurwitz D, Isackson PJ, Cunningham DD: Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. Proc Natl Acad Sci USA 86: 8284-8288, 1989
25. Degen SJF: The prothrombin gene and its liver-specific expression. Semin Thromb Hemostasis 18: 230-242, 1992
26. Tapparelli C, Metternich R, Cook NS: Structure and function of thrombin receptors. Trends Pharmacol Sci 14: 426-428, 1993